Back in the mid-2000s, Mark Zuckerberg had a pretty awesome product: a site called Facebook, which was still widely loved and not polluted with endless ads and scams.
The interceding years have been hard on Zuckerberg’s empire. From a disastrous, multibillion-dollar foray into a pandemic-era virtual reality world nobody wanted to step a foot into to effectively abandoning content moderation and allowing demented AI slop to flood its social media platforms, Meta now feels more like a dilapidated strip mall than a hot tech property.
Lately, it almost feels like Zuckerberg is trying to destroy his own company. He’s burning through mountains of cash in a desperate attempt to keep up in the AI race. Yet despite the untold billions it’s spent so far, it’s being destroyed by OpenAI and Anthropic. Its employees have even resorted to using AI models made by its competitors, a humiliating reality check for how far behind Zuckerberg’s efforts have fallen.
It’s also a financial nightmare. Capital expenditures have risen dramatically, erasing any appetite for Meta on Wall Street. Its stock price “has been dead money for more than a year,” as Yahoo Finance notes, as investors continue to debate whether Zuckerberg is chasing the AI industry as it careens off a cliff — or edging ever closer to an AI-fueled industrial revolution.
This week’s second quarter earnings, in particular, will serve as one of the biggest tests in Meta’s recent history. Another major hike in AI spending — which is looking likely, given Zuckerberg’s recent doubling down and soaring AI data center costs — could send its already flagging shares sinking even further.
It’s a precarious moment for the industry as concerns over a massive AI bubble once again grip shareholders. The news comes after Alphabet shocked skeptical investors by raising its spending forecast past the $200 billion mark last week, indicating that Zuckerberg may try something similar.
“Prior to Alphabet recently raising FY26 capex guide, we think there were limited expectations for Meta to increase its current 2026 guidance of $125-$145 billion,” Deutsche Bank analyst Benjamin Black wrote in a note. “However, now, it is likely investors fear an increase in FY26 outlook likely may be coming.”
The debt keeps piling up as companies eye even bigger AI data center build-outs. As the Wall Street Journal reports, Meta executives told bankers and fund managers that it’s looking to raise even more cash — in the “hundreds of billions of dollars” — to support the plans.
Meanwhile, spiking demand and steady interest rates have caused construction costs to soar, making these funding rounds an even bigger ask for tech execs.
Despite the massive AI spending, Zuckerberg appears to be painfully aware he’s likely steering the company in the wrong direction. Earlier this month, he conceded to staff during a town hall that the “trajectory of the agentic development over at least the last four months hasn’t really accelerated in the way that we expected.”
Meta has also been struggling with rock-bottom morale. Despite earmarking over $100 billion on AI infrastructure, the company has been laying off thousands of workers in an apparent effort to replace them with the tech.
During the town hall, Zuckerberg admitted that the major culling were not “clean,” adding that bets on restructuring “haven’t come to fruition yet.”
The company was also forced to halt a highly controversial plan to record everything workers do on their assigned computers to gather data for AI after leaking sensitive employee information.
More on Mark Zuckerberg: Meta Is Letting Fake AI-Generated Doctors Sell Quack Cures on Its Platforms
The post Is Mark Zuckerberg Actually TRYING to Destroy Meta? appeared first on Futurism.
Guardoc Health says it processes over one million clinical documents daily using Amazon Nova models through Bedrock.
Bringing AI into clinical documentation comes down to a specific kind of risk calculation. Get it wrong and the errors compound into denied Medicare claims under the Patient-Driven Payment Model, audit fines, litigation exposure, and in the worst cases, a missed condition that changes how a patient gets treated.
However, get it right and the payoff shows up in fewer corrections, fewer hospital transfers, and lower compliance costs. Guardoc Health, which builds documentation software for long-term care providers, has published deployment figures it says support that outcome.
The scale of the underlying problemGuardoc Health’s pipeline has to handle documents that arrive in nearly every format a clinical setting can produce: multi-page PDFs with handwritten physician annotations layered over printed text, prior authorisation forms where a checkbox state alone determines a coverage decision, medication lists that show up as clean tables in one chart and free text in the next, and patient intake forms mixing typed fields with rubber stamps and handwriting on the same page.
Research published in BMJ Quality and Safety puts the number of US outpatients affected by diagnostic error at around 12 million a year, with information-handling failures cited as a contributing factor. At the volume Guardoc processes, a one percent error rate in condition detection alone would generate thousands of incorrect records daily. Each one carries its own patient safety or compliance consequence.
Guardoc reports a 46 percent reduction in documentation errors, a 70 percent drop in audit fines, and more than $400,000 in annual ROI for a single facility, without publishing the baseline period or methodology behind those calculations.
In a quarterly deployment spanning two facilities and 200 patients, the company says its system drove 847 documentation corrections, flagged 86 issues tied to PDPM reimbursement accuracy, and was associated with a 74 percent reduction in hospital transfers per 100 admissions. A separate case study covering seven facilities and 1,618 residents identified 10,612 issues, according to Guardoc.
A retrieval pipeline built around cost as much as accuracyGuardoc’s architecture runs condition classification through retrieval augmented generation, pulling evidence from a patient’s own documentation before reasoning across it to produce a final answer.
Amazon Textract extracts text and structural metadata from each incoming page first, at what the company treats as the lowest per-page cost point in the pipeline. That output gets chunked along clinical boundaries, so a medication list or a diagnosis section stays intact rather than getting split by arbitrary character count.
Each chunk is embedded using Amazon Titan Text Embeddings V2 and stored in Amazon DynamoDB, partitioned by patient so retrieval never crosses patient boundaries. A custom pre-filter narrows the candidate set by document type and recency before a k-nearest neighbour search retrieves the chunks most relevant to a given classification query, returning page references only at this stage to keep data transfer light.
Amazon Nova 2 Lite then runs a text-based pass to remove obvious non-matches. Only the pages that survive every prior filter reach Amazon Nova Pro, which receives the raw PDF bytes and reasons over layout, handwriting, signatures, and stamps to produce the classification that downstream systems act on.
The design follows a cost-tiering logic throughout: cheap components handle high-volume work like embedding and coarse filtering, and the more computationally intensive multimodal reasoning gets reserved for the final stage where it’s actually required.
The hard clinical documentation casesTwo document types account for most of what earlier pipeline versions missed, according to Guardoc. The first is physician attestation fields on prior authorisation forms, where a handwritten note can override a printed checkbox. The second is patient-reported symptom sections, where handwriting often carries information that doesn’t appear anywhere else in the record.
Medication extraction presents a related problem. Drug names, dosages, routes, and frequencies show up in structured tables, in prose buried inside physician notes, in handwritten additions to printed lists, and in scans that have been faxed through multiple hands. Guardoc’s hybrid pipeline runs Amazon Textract first for clean printed tables, then passes both the original PDF and the Textract output to Amazon Nova Pro to resolve wrapped table columns, handwritten additions, and non-standard formats that OCR alone can’t parse correctly.
“With the Nova family, we’re making it easier for healthcare organisations to detect high-risk cases earlier and act before issues become costly,” said Assaf Amiaz, Director of Product at Guardoc Health. “By automating workflows that once required manual oversight, the Nova family helps teams reduce compliance gaps, prevent errors, and focus more of their time on improving patient outcomes.”
See also:How AI is shortening drug discovery timelines in China
Want to learn more about AI and big data from industry leaders? Check out AI & Big Data Expo taking place in Amsterdam, California, and London. The comprehensive event is part of TechEx and is co-located with other leading technology events including the Cyber Security & Cloud Expo. Click here for more information.
AI News is powered by TechForge Media. Explore other upcoming enterprise technology events and webinars here.
The post Guardoc Health processes clinical documentation using Amazon Nova models appeared first on AI News.